- Home
- XTNT vs ONCY Comparison
XTNT vs ONCY Comparison
Compare XTNT & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTNT
- ONCY
- Stock Information
- Founded
- XTNT N/A
- ONCY 1998
- Country
- XTNT United States
- ONCY Canada
- Employees
- XTNT N/A
- ONCY N/A
- Industry
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- ONCY Pharmaceuticals and Biotechnology
- Sector
- XTNT Health Care
- ONCY Health Care
- Exchange
- XTNT Nasdaq
- ONCY Nasdaq
- Market Cap
- XTNT 60.9M
- ONCY 49.1M
- IPO Year
- XTNT N/A
- ONCY 1999
- Fundamental
- Price
- XTNT $0.61
- ONCY $0.69
- Analyst Decision
- XTNT
- ONCY Strong Buy
- Analyst Count
- XTNT 0
- ONCY 4
- Target Price
- XTNT N/A
- ONCY $4.33
- AVG Volume (30 Days)
- XTNT 57.0K
- ONCY 1.4M
- Earning Date
- XTNT 08-07-2025
- ONCY 07-31-2025
- Dividend Yield
- XTNT N/A
- ONCY N/A
- EPS Growth
- XTNT N/A
- ONCY N/A
- EPS
- XTNT N/A
- ONCY N/A
- Revenue
- XTNT $122,298,000.00
- ONCY N/A
- Revenue This Year
- XTNT $11.64
- ONCY N/A
- Revenue Next Year
- XTNT $7.59
- ONCY N/A
- P/E Ratio
- XTNT N/A
- ONCY N/A
- Revenue Growth
- XTNT 20.81
- ONCY N/A
- 52 Week Low
- XTNT $0.33
- ONCY $0.33
- 52 Week High
- XTNT $0.83
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- XTNT 48.62
- ONCY 69.96
- Support Level
- XTNT $0.57
- ONCY $0.56
- Resistance Level
- XTNT $0.68
- ONCY $0.37
- Average True Range (ATR)
- XTNT 0.05
- ONCY 0.07
- MACD
- XTNT -0.02
- ONCY 0.04
- Stochastic Oscillator
- XTNT 30.44
- ONCY 83.26
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.